Autor: "Morimoto, M." - OpacWWW

Skocz do pozycji: 1.

Tytuł:: Risk factors for early recurrence in patients with pancreatic ductal adenocarcinoma who underwent curative resection.
Autorzy:: Murakawa M; Department of Gastrointestinal Surgery, Kanagawa Cancer Center, Yokohama City, 241-8515, Japan. m..
Kawahara S; Department of Gastrointestinal Surgery, Kanagawa Cancer Center, Yokohama City, 241-8515, Japan.
Takahashi D; Department of Gastrointestinal Surgery, Kanagawa Cancer Center, Yokohama City, 241-8515, Japan.
Kamioka Y; Department of Gastrointestinal Surgery, Kanagawa Cancer Center, Yokohama City, 241-8515, Japan.
Yamamoto N; Department of Gastrointestinal Surgery, Kanagawa Cancer Center, Yokohama City, 241-8515, Japan.
Kobayashi S; Department of Gastroenterology, Kanagawa Cancer Center, Yokohama, Japan.
Ueno M; Department of Gastroenterology, Kanagawa Cancer Center, Yokohama, Japan.
Morimoto M; Department of Gastroenterology, Kanagawa Cancer Center, Yokohama, Japan.
Sawazaki S; Department of Surgery, Yokohama City University School of Medicine, Yokohama, Japan.
Tamagawa H; Department of Surgery, Yokohama City University School of Medicine, Yokohama, Japan.
Ohshima T; Department of Gastrointestinal Surgery, Kanagawa Cancer Center, Yokohama City, 241-8515, Japan.
Yukawa N; Department of Surgery, Yokohama City University School of Medicine, Yokohama, Japan.
Rino Y; Department of Surgery, Yokohama City University School of Medicine, Yokohama, Japan.
Morinaga S; Department of Gastrointestinal Surgery, Kanagawa Cancer Center, Yokohama City, 241-8515, Japan.; Pokaż więcej
Źródło:: World journal of surgical oncology [World J Surg Oncol] 2023 Aug 24; Vol. 21 (1), pp. 263. Date of Electronic Publication: 2023 Aug 24.
Typ publikacji:: Journal Article
MeSH Terms:: Pancreatic Neoplasms*/surgery
Carcinoma, Pancreatic Ductal*/surgery
Adenocarcinoma*
Humans ; CA-19-9 Antigen ; Lymphatic Metastasis ; Risk Factors ; Pancreatic Neoplasms

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 2.

Tytuł:: Adenosquamous carcinoma coexisting with intraductal papillary mucinous neoplasm of the pancreas: a case report.
Autorzy:: Sawai H; Department of Surgery, Narita Memorial Hospital, Hanei-Honmachi 134, Toyohashi, Aichi, 4418029, Japan. .
Kiriyama Y; Department of Pathology, Narita Memorial Hospital, Toyohashi, Aichi, Japan.
Kuzuya H; Department of Surgery, Narita Memorial Hospital, Hanei-Honmachi 134, Toyohashi, Aichi, 4418029, Japan.
Fujii Y; Department of Surgery, Narita Memorial Hospital, Hanei-Honmachi 134, Toyohashi, Aichi, 4418029, Japan.
Ueno S; Department of Surgery, Narita Memorial Hospital, Hanei-Honmachi 134, Toyohashi, Aichi, 4418029, Japan.
Koide S; Department of Surgery, Narita Memorial Hospital, Hanei-Honmachi 134, Toyohashi, Aichi, 4418029, Japan.
Kurimoto M; Department of Surgery, Narita Memorial Hospital, Hanei-Honmachi 134, Toyohashi, Aichi, 4418029, Japan.
Yamao K; Department of Gastroenterology, Narita Memorial Hospital, Toyohashi, Aichi, Japan.
Matsuo Y; Department of Gastroenterological Surgery, Nagoya City University Graduate School of Medical Sciences, Kawasumi 1, Mizuho-Cho, Mizuho-Ku, Nagoya, Aichi, 467-8601, Japan.
Morimoto M; Department of Gastroenterological Surgery, Nagoya City University Graduate School of Medical Sciences, Kawasumi 1, Mizuho-Cho, Mizuho-Ku, Nagoya, Aichi, 467-8601, Japan.
Koide H; Department of Surgery, Narita Memorial Hospital, Hanei-Honmachi 134, Toyohashi, Aichi, 4418029, Japan.
Kamiya A; Department of Surgery, Narita Memorial Hospital, Hanei-Honmachi 134, Toyohashi, Aichi, 4418029, Japan.; Pokaż więcej
Źródło:: Journal of medical case reports [J Med Case Rep] 2023 Mar 02; Vol. 17 (1), pp. 72. Date of Electronic Publication: 2023 Mar 02.
Typ publikacji:: Case Reports; Journal Article
MeSH Terms:: Carcinoma, Adenosquamous*
Pancreatic Intraductal Neoplasms*
Pancreatic Neoplasms*
Carcinoma, Squamous Cell*
Adenocarcinoma*
Neoplasms, Cystic, Mucinous, and Serous*
Female ; Humans ; Aged, 80 and over ; Proto-Oncogene Proteins p21(ras) ; Pancreas ; Pancreatic Neoplasms

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 3.

Tytuł:: FOLFOX regimen after failure of fluorouracil and leucovorin plus nanoliposomal-irinotecan therapy for advanced pancreatic cancer: a retrospective observational study.
Autorzy:: Kobayashi S; Department of Gastroenterology, Kanagawa Cancer Center, 2-3-2, Nakao, Asahi-ku, Yokohama City, Kanagawa, 241-0815, Japan. .
Tezuka S; Department of Gastroenterology, Kanagawa Cancer Center, 2-3-2, Nakao, Asahi-ku, Yokohama City, Kanagawa, 241-0815, Japan.
Yamachika Y; Department of Gastroenterology, Kanagawa Cancer Center, 2-3-2, Nakao, Asahi-ku, Yokohama City, Kanagawa, 241-0815, Japan.
Tsunoda S; Department of Gastroenterology, Kanagawa Cancer Center, 2-3-2, Nakao, Asahi-ku, Yokohama City, Kanagawa, 241-0815, Japan.
Nagashima S; Department of Gastroenterology, Kanagawa Cancer Center, 2-3-2, Nakao, Asahi-ku, Yokohama City, Kanagawa, 241-0815, Japan.
Tozuka Y; Department of Gastroenterology, Kanagawa Cancer Center, 2-3-2, Nakao, Asahi-ku, Yokohama City, Kanagawa, 241-0815, Japan.
Fukushima T; Department of Gastroenterology, Kanagawa Cancer Center, 2-3-2, Nakao, Asahi-ku, Yokohama City, Kanagawa, 241-0815, Japan.
Morimoto M; Department of Gastroenterology, Kanagawa Cancer Center, 2-3-2, Nakao, Asahi-ku, Yokohama City, Kanagawa, 241-0815, Japan.
Ueno M; Department of Gastroenterology, Kanagawa Cancer Center, 2-3-2, Nakao, Asahi-ku, Yokohama City, Kanagawa, 241-0815, Japan.
Furuse J; Department of Gastroenterology, Kanagawa Cancer Center, 2-3-2, Nakao, Asahi-ku, Yokohama City, Kanagawa, 241-0815, Japan.
Maeda S; Department of Gastroenterology, Yokohama City University Graduate School of Medicine, 3-9, Fukuura, Kanazaw-ku, Yokohama City, Kanagawa, 236-0004, Japan.; Pokaż więcej
Źródło:: BMC cancer [BMC Cancer] 2023 Feb 21; Vol. 23 (1), pp. 177. Date of Electronic Publication: 2023 Feb 21.
Typ publikacji:: Observational Study; Journal Article
MeSH Terms:: Pancreatic Neoplasms*/pathology
Adenocarcinoma*/drug therapy
Humans ; Irinotecan ; Retrospective Studies ; Leucovorin ; Oxaliplatin/therapeutic use ; Anorexia/chemically induced ; Fluorouracil ; Antineoplastic Combined Chemotherapy Protocols/adverse effects ; Pancreatic Neoplasms
SCR Protocol:: Folfox protocol

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 4.

Tytuł:: Modified geriatric nutritional risk index in patients with pancreatic cancer: a propensity score-matched analysis.
Autorzy:: Sakamoto T; Division of Gastrointestinal and Pediatric Surgery, Department of Surgery, School of Medicine, Tottori University Faculty of Medicine, 36-1 Nishi-cho, Yonago, 683-8504, Japan. .
Sunaguchi T; Division of Gastrointestinal and Pediatric Surgery, Department of Surgery, School of Medicine, Tottori University Faculty of Medicine, 36-1 Nishi-cho, Yonago, 683-8504, Japan.
Goto K; Division of Gastrointestinal and Pediatric Surgery, Department of Surgery, School of Medicine, Tottori University Faculty of Medicine, 36-1 Nishi-cho, Yonago, 683-8504, Japan.
Morimoto M; Division of Gastrointestinal and Pediatric Surgery, Department of Surgery, School of Medicine, Tottori University Faculty of Medicine, 36-1 Nishi-cho, Yonago, 683-8504, Japan.
Murakami Y; Division of Gastrointestinal and Pediatric Surgery, Department of Surgery, School of Medicine, Tottori University Faculty of Medicine, 36-1 Nishi-cho, Yonago, 683-8504, Japan.
Miyatani K; Division of Gastrointestinal and Pediatric Surgery, Department of Surgery, School of Medicine, Tottori University Faculty of Medicine, 36-1 Nishi-cho, Yonago, 683-8504, Japan.
Hanaki T; Division of Gastrointestinal and Pediatric Surgery, Department of Surgery, School of Medicine, Tottori University Faculty of Medicine, 36-1 Nishi-cho, Yonago, 683-8504, Japan.
Shishido Y; Division of Gastrointestinal and Pediatric Surgery, Department of Surgery, School of Medicine, Tottori University Faculty of Medicine, 36-1 Nishi-cho, Yonago, 683-8504, Japan.
Kihara K; Division of Gastrointestinal and Pediatric Surgery, Department of Surgery, School of Medicine, Tottori University Faculty of Medicine, 36-1 Nishi-cho, Yonago, 683-8504, Japan.
Matsunaga T; Division of Gastrointestinal and Pediatric Surgery, Department of Surgery, School of Medicine, Tottori University Faculty of Medicine, 36-1 Nishi-cho, Yonago, 683-8504, Japan.
Yamamoto M; Division of Gastrointestinal and Pediatric Surgery, Department of Surgery, School of Medicine, Tottori University Faculty of Medicine, 36-1 Nishi-cho, Yonago, 683-8504, Japan.
Tokuyasu N; Division of Gastrointestinal and Pediatric Surgery, Department of Surgery, School of Medicine, Tottori University Faculty of Medicine, 36-1 Nishi-cho, Yonago, 683-8504, Japan.
Fujiwara Y; Division of Gastrointestinal and Pediatric Surgery, Department of Surgery, School of Medicine, Tottori University Faculty of Medicine, 36-1 Nishi-cho, Yonago, 683-8504, Japan.; Pokaż więcej
Źródło:: BMC cancer [BMC Cancer] 2022 Sep 12; Vol. 22 (1), pp. 974. Date of Electronic Publication: 2022 Sep 12.
Typ publikacji:: Journal Article
MeSH Terms:: Nutrition Assessment*
Pancreatic Neoplasms*/surgery
Aged ; Geriatric Assessment/methods ; Humans ; Nutritional Status ; Propensity Score ; Retrospective Studies

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 5.

Tytuł:: Geriatric nutritional risk index as a prognostic factor in patients with recurrent pancreatic cancer.
Autorzy:: Sakamoto T; Division of Gastrointestinal and Pediatric Surgery, Department of Surgery, School of Medicine, Tottori University Faculty of Medicine, Yonago, Tottori prefecture, Japan.
Makinoya M; Division of Gastrointestinal and Pediatric Surgery, Department of Surgery, School of Medicine, Tottori University Faculty of Medicine, Yonago, Tottori prefecture, Japan.
Sunaguchi T; Division of Gastrointestinal and Pediatric Surgery, Department of Surgery, School of Medicine, Tottori University Faculty of Medicine, Yonago, Tottori prefecture, Japan.
Goto K; Division of Gastrointestinal and Pediatric Surgery, Department of Surgery, School of Medicine, Tottori University Faculty of Medicine, Yonago, Tottori prefecture, Japan.
Morimoto M; Division of Gastrointestinal and Pediatric Surgery, Department of Surgery, School of Medicine, Tottori University Faculty of Medicine, Yonago, Tottori prefecture, Japan.
Murakami Y; Division of Gastrointestinal and Pediatric Surgery, Department of Surgery, School of Medicine, Tottori University Faculty of Medicine, Yonago, Tottori prefecture, Japan.
Miyatani K; Division of Gastrointestinal and Pediatric Surgery, Department of Surgery, School of Medicine, Tottori University Faculty of Medicine, Yonago, Tottori prefecture, Japan.
Hanaki T; Division of Gastrointestinal and Pediatric Surgery, Department of Surgery, School of Medicine, Tottori University Faculty of Medicine, Yonago, Tottori prefecture, Japan.
Shishido Y; Division of Gastrointestinal and Pediatric Surgery, Department of Surgery, School of Medicine, Tottori University Faculty of Medicine, Yonago, Tottori prefecture, Japan.
Kihara K; Division of Gastrointestinal and Pediatric Surgery, Department of Surgery, School of Medicine, Tottori University Faculty of Medicine, Yonago, Tottori prefecture, Japan.
Matsunaga T; Division of Gastrointestinal and Pediatric Surgery, Department of Surgery, School of Medicine, Tottori University Faculty of Medicine, Yonago, Tottori prefecture, Japan.
Yamamoto M; Division of Gastrointestinal and Pediatric Surgery, Department of Surgery, School of Medicine, Tottori University Faculty of Medicine, Yonago, Tottori prefecture, Japan.
Tokuyasu N; Division of Gastrointestinal and Pediatric Surgery, Department of Surgery, School of Medicine, Tottori University Faculty of Medicine, Yonago, Tottori prefecture, Japan.
Fujiwara Y; Division of Gastrointestinal and Pediatric Surgery, Department of Surgery, School of Medicine, Tottori University Faculty of Medicine, Yonago, Tottori prefecture, Japan.; Pokaż więcej
Źródło:: PloS one [PLoS One] 2022 Jul 07; Vol. 17 (7), pp. e0271073. Date of Electronic Publication: 2022 Jul 07 (Print Publication: 2022).
Typ publikacji:: Journal Article
MeSH Terms:: Nutrition Assessment*
Pancreatic Neoplasms*/complications
Pancreatic Neoplasms*/diagnosis
Pancreatic Neoplasms*/surgery
Aged ; Geriatric Assessment ; Humans ; Nutritional Status ; Prognosis ; Recurrence ; Retrospective Studies ; Risk Factors ; Pancreatic Neoplasms

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 6.

Tytuł:: Modified FOLFIRINOX versus sequential chemotherapy (FOLFIRI/FOLFOX) as a second-line treatment regimen for unresectable pancreatic cancer: A real-world analysis.
Autorzy:: Tezuka S; Department of Hepatobiliary and Pancreatic Medical Oncology, Kanagawa Cancer Center, Yokohama, Japan.
Ueno M; Department of Hepatobiliary and Pancreatic Medical Oncology, Kanagawa Cancer Center, Yokohama, Japan.
Oishi R; Department of Hepatobiliary and Pancreatic Medical Oncology, Kanagawa Cancer Center, Yokohama, Japan.
Nagashima S; Department of Hepatobiliary and Pancreatic Medical Oncology, Kanagawa Cancer Center, Yokohama, Japan.
Sano Y; Department of Hepatobiliary and Pancreatic Medical Oncology, Kanagawa Cancer Center, Yokohama, Japan.
Kawano K; Department of Hepatobiliary and Pancreatic Medical Oncology, Kanagawa Cancer Center, Yokohama, Japan.
Tanaka S; Department of Hepatobiliary and Pancreatic Medical Oncology, Kanagawa Cancer Center, Yokohama, Japan.
Fukushima T; Department of Hepatobiliary and Pancreatic Medical Oncology, Kanagawa Cancer Center, Yokohama, Japan.
Asama H; Department of Hepatobiliary and Pancreatic Medical Oncology, Kanagawa Cancer Center, Yokohama, Japan.
Konno N; Department of Hepatobiliary and Pancreatic Medical Oncology, Kanagawa Cancer Center, Yokohama, Japan.
Kobayashi S; Department of Hepatobiliary and Pancreatic Medical Oncology, Kanagawa Cancer Center, Yokohama, Japan.
Morimoto M; Department of Hepatobiliary and Pancreatic Medical Oncology, Kanagawa Cancer Center, Yokohama, Japan.
Maeda S; Department of Gastroenterology, Yokohama City University Graduate School of Medicine, Yokohama, Japan.; Pokaż więcej
Źródło:: Cancer medicine [Cancer Med] 2022 Feb; Vol. 11 (4), pp. 1088-1098. Date of Electronic Publication: 2021 Dec 24.
Typ publikacji:: Journal Article
MeSH Terms:: Antineoplastic Combined Chemotherapy Protocols*/adverse effects
Pancreatic Neoplasms*
Fluorouracil/adverse effects ; Humans ; Irinotecan ; Leucovorin/adverse effects ; Oxaliplatin ; Retrospective Studies ; Pancreatic Neoplasms

Czasopismo naukowe

na półce

Pełny tekst Szczegóły

Skocz do pozycji: 7.

Tytuł:: Randomized Phase II Study of Gemcitabine Monotherapy vs. Gemcitabine with an EPA-Enriched Oral Supplement in Advanced Pancreatic Cancer.
Autorzy:: Ueno M; Division of Hepatobiliary and Pancreatic Medical Oncology, Kanagawa Cancer Center, Yokohama, Japan.
Sugimori K; Department of Gastroenterology, Yokohama City University Medical Center, Yokohama, Japan.
Taguri M; Department of Biostatistics and Epidemiology, Yokohama City University Medical Center, Yokohama, Japan.
Ohkawa S; Division of Hepatobiliary and Pancreatic Medical Oncology, Kanagawa Cancer Center, Yokohama, Japan.
Kobayashi S; Division of Hepatobiliary and Pancreatic Medical Oncology, Kanagawa Cancer Center, Yokohama, Japan.
Miwa H; Department of Gastroenterology, Yokohama City University Medical Center, Yokohama, Japan.
Kaneko T; Department of Gastroenterology, Yokohama City University Medical Center, Yokohama, Japan.
Morimoto M; Division of Hepatobiliary and Pancreatic Medical Oncology, Kanagawa Cancer Center, Yokohama, Japan.
Yamanaka T; Department of Biostatistics and Epidemiology, Yokohama City University Medical Center, Yokohama, Japan.; Pokaż więcej
Źródło:: Nutrition and cancer [Nutr Cancer] 2022; Vol. 74 (1), pp. 122-130. Date of Electronic Publication: 2021 Jan 13.
Typ publikacji:: Clinical Trial, Phase II; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
MeSH Terms:: Eicosapentaenoic Acid*/therapeutic use
Pancreatic Neoplasms*/drug therapy
Antineoplastic Combined Chemotherapy Protocols/therapeutic use ; Deoxycytidine/analogs & derivatives ; Humans ; Male ; Pancreas ; Gemcitabine

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 8.

Tytuł:: Human chromosome 3p21.3 carries TERT transcriptional regulators in pancreatic cancer.
Autorzy:: Yagyu T; Division of Gastrointestinal and Pediatric Surgery, Department of Surgery, School of Medicine, Faculty of Medicine, Tottori University, Yonago, Tottori, Japan.; Department of Molecular and Cellular Biology, Division of Genome and Cellular Function, Tottori University, Yonago, Tottori, Japan.
Ohira T; Department of Molecular and Cellular Biology, Division of Genome and Cellular Function, Tottori University, Yonago, Tottori, Japan.; Chromosome Engineering Research Center, Tottori University, Yonago, Tottori, Japan.
Shimizu R; Department of Molecular and Cellular Biology, Division of Genome and Cellular Function, Tottori University, Yonago, Tottori, Japan.; Division of Urology, Department of Surgery, Faculty of Medicine, Tottori University, Yonago, Tottori, Japan.
Morimoto M; Division of Gastrointestinal and Pediatric Surgery, Department of Surgery, School of Medicine, Faculty of Medicine, Tottori University, Yonago, Tottori, Japan.
Murakami Y; Division of Gastrointestinal and Pediatric Surgery, Department of Surgery, School of Medicine, Faculty of Medicine, Tottori University, Yonago, Tottori, Japan.
Hanaki T; Division of Gastrointestinal and Pediatric Surgery, Department of Surgery, School of Medicine, Faculty of Medicine, Tottori University, Yonago, Tottori, Japan.
Kihara K; Division of Gastrointestinal and Pediatric Surgery, Department of Surgery, School of Medicine, Faculty of Medicine, Tottori University, Yonago, Tottori, Japan.
Matsunaga T; Division of Gastrointestinal and Pediatric Surgery, Department of Surgery, School of Medicine, Faculty of Medicine, Tottori University, Yonago, Tottori, Japan.
Yamamoto M; Division of Gastrointestinal and Pediatric Surgery, Department of Surgery, School of Medicine, Faculty of Medicine, Tottori University, Yonago, Tottori, Japan.
Tokuyasu N; Division of Gastrointestinal and Pediatric Surgery, Department of Surgery, School of Medicine, Faculty of Medicine, Tottori University, Yonago, Tottori, Japan.
Sakamoto T; Division of Gastrointestinal and Pediatric Surgery, Department of Surgery, School of Medicine, Faculty of Medicine, Tottori University, Yonago, Tottori, Japan.
Fujiwara Y; Division of Gastrointestinal and Pediatric Surgery, Department of Surgery, School of Medicine, Faculty of Medicine, Tottori University, Yonago, Tottori, Japan.
Kugoh H; Department of Molecular and Cellular Biology, Division of Genome and Cellular Function, Tottori University, Yonago, Tottori, Japan. .; Chromosome Engineering Research Center, Tottori University, Yonago, Tottori, Japan. .; Pokaż więcej
Źródło:: Scientific reports [Sci Rep] 2021 Jul 28; Vol. 11 (1), pp. 15355. Date of Electronic Publication: 2021 Jul 28.
Typ publikacji:: Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:: Loss of Heterozygosity*
Carcinogenesis/*genetics
Chimera/*genetics
Chromosomes, Human, Pair 3/*chemistry
Pancreatic Neoplasms/*genetics
Telomerase/*genetics
Animals ; Carcinogenesis/metabolism ; Carcinogenesis/pathology ; Cell Line, Tumor ; Cell Proliferation ; Chromosomes, Human, Pair 3/metabolism ; Gene Expression Regulation, Neoplastic ; Humans ; Mice ; Neoplasm Invasiveness ; Pancreatic Neoplasms/metabolism ; Pancreatic Neoplasms/pathology ; Promoter Regions, Genetic ; Telomerase/metabolism ; Transcription, Genetic

Czasopismo naukowe

na półce

Pełny tekst Szczegóły

Skocz do pozycji: 9.

Tytuł:: Association between time to stent dysfunction and the anti-tumour effect of systemic chemotherapy following stent placement in patients with pancreaticobiliary cancers and malignant gastric outlet obstruction: a retrospective cohort study.
Autorzy:: Kobayashi S; Department of Gastroenterology, Hepatobiliary and Pancreatic Medical Oncology Division, Kanagawa Cancer Center, 2-3-2, Nakao, Asahi-ku, Yokohama City, 241-0815, Japan. .
Ueno M; Department of Gastroenterology, Hepatobiliary and Pancreatic Medical Oncology Division, Kanagawa Cancer Center, 2-3-2, Nakao, Asahi-ku, Yokohama City, 241-0815, Japan.
Nagashima S; Department of Gastroenterology, Hepatobiliary and Pancreatic Medical Oncology Division, Kanagawa Cancer Center, 2-3-2, Nakao, Asahi-ku, Yokohama City, 241-0815, Japan.
Sano Y; Department of Gastroenterology, Hepatobiliary and Pancreatic Medical Oncology Division, Kanagawa Cancer Center, 2-3-2, Nakao, Asahi-ku, Yokohama City, 241-0815, Japan.
Kawano K; Department of Gastroenterology, Hepatobiliary and Pancreatic Medical Oncology Division, Kanagawa Cancer Center, 2-3-2, Nakao, Asahi-ku, Yokohama City, 241-0815, Japan.
Fukushima T; Department of Gastroenterology, Hepatobiliary and Pancreatic Medical Oncology Division, Kanagawa Cancer Center, 2-3-2, Nakao, Asahi-ku, Yokohama City, 241-0815, Japan.
Asama H; Department of Gastroenterology, Hepatobiliary and Pancreatic Medical Oncology Division, Kanagawa Cancer Center, 2-3-2, Nakao, Asahi-ku, Yokohama City, 241-0815, Japan.
Tezuka S; Department of Gastroenterology, Hepatobiliary and Pancreatic Medical Oncology Division, Kanagawa Cancer Center, 2-3-2, Nakao, Asahi-ku, Yokohama City, 241-0815, Japan.
Morimoto M; Department of Gastroenterology, Hepatobiliary and Pancreatic Medical Oncology Division, Kanagawa Cancer Center, 2-3-2, Nakao, Asahi-ku, Yokohama City, 241-0815, Japan.; Pokaż więcej
Źródło:: BMC cancer [BMC Cancer] 2021 May 19; Vol. 21 (1), pp. 576. Date of Electronic Publication: 2021 May 19.
Typ publikacji:: Journal Article
MeSH Terms:: Antineoplastic Combined Chemotherapy Protocols/*therapeutic use
Endoscopy, Gastrointestinal/*adverse effects
Equipment Failure/*statistics & numerical data
Gastric Outlet Obstruction/*surgery
Gastrointestinal Neoplasms/*drug therapy
Pancreatic Neoplasms/*drug therapy
Adult ; Aged ; Aged, 80 and over ; Endoscopy, Gastrointestinal/instrumentation ; Endoscopy, Gastrointestinal/methods ; Endoscopy, Gastrointestinal/statistics & numerical data ; Female ; Gastric Bypass/statistics & numerical data ; Gastric Outlet Obstruction/etiology ; Gastrointestinal Neoplasms/complications ; Gastrointestinal Neoplasms/mortality ; Gastrointestinal Neoplasms/pathology ; Humans ; Incidence ; Male ; Middle Aged ; Neoplasm Invasiveness ; Pancreatic Neoplasms/complications ; Pancreatic Neoplasms/mortality ; Pancreatic Neoplasms/pathology ; Progression-Free Survival ; Retrospective Studies ; Stents/adverse effects ; Stents/statistics & numerical data ; Time Factors

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 10.

Tytuł:: The age-adjusted Charlson comorbidity index is an independent prognostic factor in pancreatic cancer patients who receive curative resection followed by adjuvant chemotherapy.
Autorzy:: Aoyama T; Department of Gastrointestinal Surgery, Kanagawa Cancer Center, Yokohama, Kanagawa, Japan; Department of Surgery, Yokohama City University, Yokohama, Kanagawa, Japan.
Yamamoto N; Department of Gastrointestinal Surgery, Kanagawa Cancer Center, Yokohama, Kanagawa, Japan; Department of Surgery, Yokohama City University, Yokohama, Kanagawa, Japan.
Kamiya M; Department of Gastrointestinal Surgery, Kanagawa Cancer Center, Yokohama, Kanagawa, Japan; Department of Surgery, Yokohama City University, Yokohama, Kanagawa, Japan.
Murakawa M; Department of Gastrointestinal Surgery, Kanagawa Cancer Center, Yokohama, Kanagawa, Japan; Department of Surgery, Yokohama City University, Yokohama, Kanagawa, Japan.
Tamagawa H; Department of Gastrointestinal Surgery, Kanagawa Cancer Center, Yokohama, Kanagawa, Japan; Department of Surgery, Yokohama City University, Yokohama, Kanagawa, Japan.
Sawazaki S; Department of Surgery, Yokohama City University, Yokohama, Kanagawa, Japan.
Numata M; Department of Surgery, Yokohama City University, Yokohama, Kanagawa, Japan.
Kobayashi S; Department of Gastroenterology, Division of Hepatobiliary and Pancreatic Medical Oncology, Kanagawa Cancer Center, Yokohama, Kanagawa, Japan.
Ueno M; Department of Gastroenterology, Division of Hepatobiliary and Pancreatic Medical Oncology, Kanagawa Cancer Center, Yokohama, Kanagawa, Japan.
Morimoto M; Department of Gastroenterology, Division of Hepatobiliary and Pancreatic Medical Oncology, Kanagawa Cancer Center, Yokohama, Kanagawa, Japan.
Shiozawa M; Department of Gastrointestinal Surgery, Kanagawa Cancer Center, Yokohama, Kanagawa, Japan.
Yukawa N; Department of Surgery, Yokohama City University, Yokohama, Kanagawa, Japan.
Oshima T; Department of Surgery, Yokohama City University, Yokohama, Kanagawa, Japan.
Yoshikawa T; Department of Surgery, Yokohama City University, Yokohama, Kanagawa, Japan.
Rino Y; Department of Surgery, Yokohama City University, Yokohama, Kanagawa, Japan.
Masuda M; Department of Surgery, Yokohama City University, Yokohama, Kanagawa, Japan.
Morinaga S; Department of Gastrointestinal Surgery, Kanagawa Cancer Center, Yokohama, Kanagawa, Japan; Department of Surgery, Yokohama City University, Yokohama, Kanagawa, Japan.; Pokaż więcej
Źródło:: Journal of cancer research and therapeutics [J Cancer Res Ther] 2020 Dec; Vol. 16 (Supplement), pp. S116-S121.
Typ publikacji:: Journal Article
MeSH Terms:: Pancreatectomy*
Antimetabolites, Antineoplastic/*therapeutic use
Neoplasm Recurrence, Local/*epidemiology
Pancreatic Neoplasms/*therapy
Adult ; Age Factors ; Aged ; Aged, 80 and over ; Chemotherapy, Adjuvant ; Comorbidity ; Deoxycytidine/analogs & derivatives ; Deoxycytidine/therapeutic use ; Disease-Free Survival ; Female ; Follow-Up Studies ; Humans ; Male ; Middle Aged ; Neoplasm Recurrence, Local/prevention & control ; Pancreatic Neoplasms/mortality ; Prognosis ; Retrospective Studies ; Risk Assessment/methods ; Risk Assessment/statistics & numerical data ; Risk Factors ; Survival Rate ; Gemcitabine

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 11.

Tytuł:: Invasive Ductal Carcinoma Arising in Mucinous Cystic Neoplasm of Pancreas: A Case Report.
Autorzy:: Sawai H; Department of Surgery, Narita Memorial Hospital, Toyohashi, Aichi, Japan.
Kurimoto M; Department of Surgery, Narita Memorial Hospital, Toyohashi, Aichi, Japan.
Koide S; Department of Surgery, Narita Memorial Hospital, Toyohashi, Aichi, Japan.
Kiriyama Y; Department of Pathology, Narita Memorial Hospital, Toyohashi, Aichi, Japan.
Haba S; Department of Gastroenterology, Narita Memorial Hospital, Toyohashi, Aichi, Japan.
Matsuo Y; Department of Gastroenterological Surgery, Nagoya City University Graduate School of Medical Sciences, Nagoya, Aichi, Japan.
Morimoto M; Department of Gastroenterological Surgery, Nagoya City University Graduate School of Medical Sciences, Nagoya, Aichi, Japan.
Koide H; Department of Surgery, Narita Memorial Hospital, Toyohashi, Aichi, Japan.
Kamiya A; Department of Surgery, Narita Memorial Hospital, Toyohashi, Aichi, Japan.
Yamao K; Department of Gastroenterology, Narita Memorial Hospital, Toyohashi, Aichi, Japan.; Pokaż więcej
Źródło:: The American journal of case reports [Am J Case Rep] 2019 Feb 24; Vol. 20, pp. 242-247. Date of Electronic Publication: 2019 Feb 24.
Typ publikacji:: Case Reports; Journal Article
MeSH Terms:: Carcinoma, Pancreatic Ductal/*pathology
Cystadenoma, Mucinous/*pathology
Neoplasms, Multiple Primary/*pathology
Pancreatic Neoplasms/*pathology
Adult ; Female ; Humans ; Mutation ; Neoplasm Invasiveness ; Proto-Oncogene Proteins p21(ras)/genetics

Czasopismo naukowe

na półce

Pełny tekst Szczegóły

Skocz do pozycji: 12.

Tytuł:: Survival and the prognosticators of peritoneal cytology-positive pancreatic cancer patients undergoing curative resection followed by adjuvant chemotherapy.
Autorzy:: Aoyama T; Department of Gastrointestinal Surgery, Kanagawa Cancer Center, Yokohama, Japan.
Atsumi Y; Department of Gastrointestinal Surgery, Kanagawa Cancer Center, Yokohama, Japan.
Kazama K; Department of Gastrointestinal Surgery, Kanagawa Cancer Center, Yokohama, Japan.
Murakawa M; Department of Gastrointestinal Surgery, Kanagawa Cancer Center, Yokohama, Japan.
Shiozawa M; Department of Gastrointestinal Surgery, Kanagawa Cancer Center, Yokohama, Japan.
Kobayashi S; Department of Hepatobiliary Pancreatic Oncology, Kanagawa Cancer Center, Yokohama, Japan.
Ueno M; Department of Hepatobiliary Pancreatic Oncology, Kanagawa Cancer Center, Yokohama, Japan.
Morimoto M; Department of Hepatobiliary Pancreatic Oncology, Kanagawa Cancer Center, Yokohama, Japan.
Yukawa N; Department of Surgery, Yokohama City University, Yokohama, Japan.
Oshima T; Department of Surgery, Yokohama City University, Yokohama, Japan.
Yoshikawa T; Department of Surgery, Yokohama City University, Yokohama, Japan.
Rino Y; Department of Surgery, Yokohama City University, Yokohama, Japan.
Masuda M; Department of Surgery, Yokohama City University, Yokohama, Japan.
Morinaga S; Department of Gastrointestinal Surgery, Kanagawa Cancer Center, Yokohama, Japan.; Pokaż więcej
Źródło:: Journal of cancer research and therapeutics [J Cancer Res Ther] 2018 Dec; Vol. 14 (Supplement), pp. S1129-S1134.
Typ publikacji:: Journal Article
MeSH Terms:: Pancreatectomy*
Antineoplastic Agents/*therapeutic use
Lymph Nodes/*pathology
Pancreatic Neoplasms/*mortality
Aged ; Biopsy/methods ; Chemotherapy, Adjuvant/methods ; Disease-Free Survival ; Female ; Follow-Up Studies ; Humans ; Kaplan-Meier Estimate ; Lymphatic Metastasis ; Male ; Middle Aged ; Neoplasm Staging ; Pancreas/pathology ; Pancreas/surgery ; Pancreatic Neoplasms/pathology ; Pancreatic Neoplasms/therapy ; Peritoneal Lavage/methods ; Prognosis ; Survival Rate ; Treatment Outcome

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 13.

Tytuł:: Prediction model for pancreatic cancer risk in the general Japanese population.
Autorzy:: Nakatochi M; Division of Data Science, Data Coordinating Center, Department of Advanced Medicine, Nagoya University Hospital, Nagoya, Japan.
Lin Y; Department of Public Health, Aichi Medical University School of Medicine, Nagakute, Japan.
Ito H; Division of Cancer Information and Control, Aichi Cancer Center Research Institute, Nagoya, Japan.
Hara K; Department of Gastroenterology, Aichi Cancer Center Hospital, Nagoya, Japan.
Kinoshita F; Division of Data Science, Data Coordinating Center, Department of Advanced Medicine, Nagoya University Hospital, Nagoya, Japan.
Kobayashi Y; Division of Data Science, Data Coordinating Center, Department of Advanced Medicine, Nagoya University Hospital, Nagoya, Japan.
Ishii H; Clinical Research Center, National Hospital Organization Shikoku Cancer Center, Matsuyama, Japan.
Ozaka M; Department of Hepato-biliary-pancreatic Medicine, The Cancer Institute Hospital of Japanese Foundation for Cancer Research, Tokyo, Japan.
Sasaki T; Department of Hepato-biliary-pancreatic Medicine, The Cancer Institute Hospital of Japanese Foundation for Cancer Research, Tokyo, Japan.
Sasahira N; Department of Hepato-biliary-pancreatic Medicine, The Cancer Institute Hospital of Japanese Foundation for Cancer Research, Tokyo, Japan.
Morimoto M; Hepatobiliary and Pancreatic Medical Oncology Division, Kanagawa Cancer Center Hospital, Kanagawa, Japan.
Kobayashi S; Hepatobiliary and Pancreatic Medical Oncology Division, Kanagawa Cancer Center Hospital, Kanagawa, Japan.
Ueno M; Hepatobiliary and Pancreatic Medical Oncology Division, Kanagawa Cancer Center Hospital, Kanagawa, Japan.
Ohkawa S; Hepatobiliary and Pancreatic Medical Oncology Division, Kanagawa Cancer Center Hospital, Kanagawa, Japan.
Egawa N; Tokyo Metropolitan Hiroo Hospital, Tokyo, Japan.
Kuruma S; Department of Internal Medicine, Tokyo Metropolitan Komagome Hospital, Tokyo, Japan.
Mori M; Hokkaido Chitose College of Rehabilitation, Hokkaido, Japan.
Nakao H; Division of Hepatology and Pancreatology, Aichi Medical University School of Medicine, Nagakute, Japan.
Wang C; Department of Public Health, Aichi Medical University School of Medicine, Nagakute, Japan.
Nishiyama T; Department of Public Health, Nagoya City University Graduate School of Medicine, Nagoya, Japan.
Kawaguchi T; Center for Genomic Medicine, Graduate School of Medicine, Kyoto University, Kyoto, Japan.
Takahashi M; Center for Genomic Medicine, Graduate School of Medicine, Kyoto University, Kyoto, Japan.
Matsuda F; Center for Genomic Medicine, Graduate School of Medicine, Kyoto University, Kyoto, Japan.
Kikuchi S; Department of Public Health, Aichi Medical University School of Medicine, Nagakute, Japan.
Matsuo K; Division of Cancer Epidemiology and Prevention, Aichi Cancer Center Research Institute, Nagoya, Japan.; Pokaż więcej
Źródło:: PloS one [PLoS One] 2018 Sep 07; Vol. 13 (9), pp. e0203386. Date of Electronic Publication: 2018 Sep 07 (Print Publication: 2018).
Typ publikacji:: Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:: Polymorphism, Single Nucleotide*
Genetic Predisposition to Disease/*genetics
Genome-Wide Association Study/*methods
Pancreatic Neoplasms/*genetics
Aged ; Alleles ; Asian People/genetics ; Case-Control Studies ; Cohort Studies ; Female ; Gene Frequency ; Genetic Predisposition to Disease/ethnology ; Genotype ; Humans ; Japan ; Logistic Models ; Male ; Middle Aged ; Models, Genetic ; Pancreatic Neoplasms/ethnology ; Risk Factors

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 14.

Tytuł:: Safety and feasibility of enhanced recovery after surgery in the patients underwent distal pancreatectomy for pancreatic cancer.
Autorzy:: Aoyama T; Department of Gastrointestinal Surgery, Kanagawa Cancer Center; Department of Surgery, Yokohama City University, Yokohama, Kanagawa, Japan.
Kazama K; Department of Gastrointestinal Surgery, Kanagawa Cancer Center, Yokohama, Kanagawa, Japan.
Murakawa M; Department of Gastrointestinal Surgery, Kanagawa Cancer Center, Yokohama, Kanagawa, Japan.
Atsumi Y; Department of Gastrointestinal Surgery, Kanagawa Cancer Center, Yokohama, Kanagawa, Japan.
Shiozawa M; Department of Gastrointestinal Surgery, Kanagawa Cancer Center, Yokohama, Kanagawa, Japan.
Ueno M; Department of Hepatobiliary Pancreatic Oncology, Kanagawa Cancer Center, Yokohama, Kanagawa, Japan.
Morimoto M; Department of Hepatobiliary Pancreatic Oncology, Kanagawa Cancer Center, Yokohama, Kanagawa, Japan.
Taniguchi H; Department of Anesthesiology, Kanagawa Cancer Center, Yokohama, Kanagawa, Japan.
Masuda M; Department of Surgery, Yokohama City University, Yokohama, Kanagawa, Japan.
Morinaga S; Department of Gastrointestinal Surgery, Kanagawa Cancer Center, Yokohama, Kanagawa, Japan.; Pokaż więcej
Źródło:: Journal of cancer research and therapeutics [J Cancer Res Ther] 2018 Sep; Vol. 14 (Supplement), pp. S724-S729.
Typ publikacji:: Journal Article
MeSH Terms:: Pancreatic Neoplasms/*physiopathology
Pancreatic Neoplasms/*surgery
Postoperative Complications/*physiopathology
Adult ; Aged ; Female ; Humans ; Length of Stay ; Male ; Middle Aged ; Pancreatectomy/adverse effects ; Pancreatic Neoplasms/rehabilitation ; Patient Readmission ; Perioperative Care ; Postoperative Period ; Treatment Outcome

Czasopismo naukowe

na półce

Pełny tekst Szczegóły

Skocz do pozycji: 15.

Tytuł:: Enhancement of the CXCL12/CXCR4 axis due to acquisition of gemcitabine resistance in pancreatic cancer: effect of CXCR4 antagonists.
Autorzy:: Morimoto M; Department of Gastroenterological Surgery, Nagoya City University Graduate School of Medical Science, Kawasumi 1, Mizuho-cho, Mizuhoku, Nagoya, 467-8601, Japan.
Matsuo Y; Department of Gastroenterological Surgery, Nagoya City University Graduate School of Medical Science, Kawasumi 1, Mizuho-cho, Mizuhoku, Nagoya, 467-8601, Japan. .
Koide S; Department of Gastroenterological Surgery, Nagoya City University Graduate School of Medical Science, Kawasumi 1, Mizuho-cho, Mizuhoku, Nagoya, 467-8601, Japan.
Tsuboi K; Department of Gastroenterological Surgery, Nagoya City University Graduate School of Medical Science, Kawasumi 1, Mizuho-cho, Mizuhoku, Nagoya, 467-8601, Japan.
Shamoto T; Department of Gastroenterological Surgery, Nagoya City University Graduate School of Medical Science, Kawasumi 1, Mizuho-cho, Mizuhoku, Nagoya, 467-8601, Japan.
Sato T; Department of Gastroenterological Surgery, Nagoya City University Graduate School of Medical Science, Kawasumi 1, Mizuho-cho, Mizuhoku, Nagoya, 467-8601, Japan.
Saito K; Department of Gastroenterological Surgery, Nagoya City University Graduate School of Medical Science, Kawasumi 1, Mizuho-cho, Mizuhoku, Nagoya, 467-8601, Japan.
Takahashi H; Department of Gastroenterological Surgery, Nagoya City University Graduate School of Medical Science, Kawasumi 1, Mizuho-cho, Mizuhoku, Nagoya, 467-8601, Japan.
Takeyama H; Department of Gastroenterological Surgery, Nagoya City University Graduate School of Medical Science, Kawasumi 1, Mizuho-cho, Mizuhoku, Nagoya, 467-8601, Japan.; Pokaż więcej
Źródło:: BMC cancer [BMC Cancer] 2016 May 12; Vol. 16, pp. 305. Date of Electronic Publication: 2016 May 12.
Typ publikacji:: Journal Article
MeSH Terms:: Chemokine CXCL12/*metabolism
Deoxycytidine/*analogs & derivatives
Heterocyclic Compounds, 1-Ring/*pharmacology
Pancreatic Neoplasms/*metabolism
Receptors, CXCR4/*antagonists & inhibitors
Receptors, CXCR4/*metabolism
Aminoquinolines ; Animals ; Antimetabolites, Antineoplastic/pharmacology ; Apoptosis/drug effects ; Benzimidazoles ; Butylamines ; Cell Proliferation/drug effects ; Deoxycytidine/pharmacology ; Female ; Fibroblasts/drug effects ; Fibroblasts/metabolism ; Fibroblasts/pathology ; Humans ; Mice ; Mice, Inbred BALB C ; Mice, Nude ; Pancreatic Neoplasms/drug therapy ; Pancreatic Neoplasms/pathology ; Stromal Cells/drug effects ; Stromal Cells/metabolism ; Stromal Cells/pathology ; Tumor Cells, Cultured ; Xenograft Model Antitumor Assays ; Gemcitabine

Czasopismo naukowe

na półce

Pełny tekst Szczegóły

Skocz do pozycji: 16.

Tytuł:: Genome-wide association study-identified SNPs (rs3790844, rs3790843) in the NR5A2 gene and risk of pancreatic cancer in Japanese.
Autorzy:: Ueno M; Hepatobiliary and Pancreatic Medical Oncology Division, Kanagawa Cancer Center Hospital, Kanagawa 241-8515, Japan.
Ohkawa S; Hepatobiliary and Pancreatic Medical Oncology Division, Kanagawa Cancer Center Hospital, Kanagawa 241-8515, Japan.
Morimoto M; Hepatobiliary and Pancreatic Medical Oncology Division, Kanagawa Cancer Center Hospital, Kanagawa 241-8515, Japan.
Ishii H; Hepatobiliary and Pancreatic Section, Gastroenterological Division, Cancer Institute Hospital, Tokyo 135-8550, Japan.
Matsuyama M; Hepatobiliary and Pancreatic Section, Gastroenterological Division, Cancer Institute Hospital, Tokyo 135-8550, Japan.
Kuruma S; Department of Internal Medicine, Tokyo Metropolitan Komagome Hospital, Tokyo 113-8677, Japan.
Egawa N; Tokyo Metropolitan Ohtsuka Hospital, Tokyo 170-8476, Japan.
Nakao H; Division of Gastroenterology, Department of Internal Medicine, Aichi Medical University School of Medicine, Nagakute 480-1195, Japan.
Mori M; Department of Public Health, Sapporo Medical University School of Medicine, Sapporo 060-0061, Japan.
Matsuo K; Division of Molecular Medicine, Aichi Cancer Center Research Insitute, Nagoya 762-6111, Japan.; Department of Epidemiology, Nagoya University Graduate School of Medicine, Nagoya 466-8550, Japan.
Hosono S; Division of Epidemiology and Prevention, Aichi Cancer Center Research Institute, Nagoya 762-6111, Japan.
Nojima M; Department of Public Health, Sapporo Medical University School of Medicine, Sapporo 060-0061, Japan.
Wakai K; Department of Preventive Medicine, Nagoya University Graduate School of Medicine, Nagoya 466-8550, Japan.
Nakamura K; Department of Food and Nutrition, Gifu City Women's College, Gifu 501-2592, Japan.
Tamakoshi A; Department of Public Health, Hokkaido University Graduate School of Medicine, Sapporo 060-8638, Japan.
Takahashi M; Central Animal Division, National Cancer Center Research Institute, Tokyo 104-0045, Japan.
Shimada K; Department of Hepatobiliary and Pancreatic Surgery, National Cancer Center Hospital, Tokyo 104-0045, Japan.
Nishiyama T; Department of Public Health, Aichi Medical University School of Medicine, Nagakute 480-1195, Japan.
Kikuchi S; Department of Public Health, Aichi Medical University School of Medicine, Nagakute 480-1195, Japan.
Lin Y; Department of Public Health, Aichi Medical University School of Medicine, Nagakute 480-1195, Japan.; Pokaż więcej
Źródło:: Scientific reports [Sci Rep] 2015 Nov 23; Vol. 5, pp. 17018. Date of Electronic Publication: 2015 Nov 23.
Typ publikacji:: Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:: Genetic Predisposition to Disease*
Polymorphism, Single Nucleotide*
Adenocarcinoma/*genetics
Pancreatic Neoplasms/*genetics
Receptors, Cytoplasmic and Nuclear/*genetics
Adenocarcinoma/ethnology ; Adenocarcinoma/pathology ; Aged ; Alleles ; Asian People ; Case-Control Studies ; Female ; Gene Expression ; Gene Frequency ; Genome-Wide Association Study ; Humans ; Linkage Disequilibrium ; Logistic Models ; Male ; Middle Aged ; Neoplasm Staging ; Odds Ratio ; Pancreatic Neoplasms/ethnology ; Pancreatic Neoplasms/pathology ; White People

Czasopismo naukowe

na półce

Pełny tekst Szczegóły

Informacja

Wyszukujesz frazę ""Morimoto, M."" wg kryterium: Autor

Źródło danych

Ogranicz do:

Ogranicz do bazy

Typ dokumentu

Temat

Wydawca

Publikacja

Język